References
- Ai G, Liu Q, Hua W, et al. (2013). Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: in vitro and in vivo studies. J Ethnopharmacol, 146, 794–802. doi:10.1016/j.jep.2013.02.005
- Ajuwon OR, Oguntibeju OO, Marnewick JL. (2014). Amelioration of lipopolysaccharide-induced liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and oxidative stress. BMC Complement Altern Med, 14, 392. doi:10.1186/1472-6882-14-392
- Carrillo MC, Kanai S, Nokubo M, Kitani K. (1991). (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci, 48, 517–521. doi:10.1016/0024-3205(91)90466-O
- Charchaflieh J, Labaze GI, Li P, et al. (2012). Overexpression of human SOD1 improves survival of mice susceptible to endotoxic shock. J Inflamm Res, 5, 51–58.
- Dhingra K. (1999). Antiestrogens–tamoxifen, SERMs and beyond. Invest New Drugs, 17, 285–311. doi:10.1023/A:1006348907994
- Galanos C, Freudenberg MA, Reutter W. (1979). Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A, 76, 5939–5943. doi:10.1073/pnas.76.11.5939
- Grainger DJ, Schofield PM. (2005). Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence. Circulation, 112, 3018–3024.
- Grek A, Arasi L. (2016). Acute liver failure. AACN Adv Crit Care, 27, 420–429. doi:10.4037/aacnacc2016324
- Guicciardi ME, Malhi H, Mott JL, et al. (2013). Apoptosis and necrosis in the liver. Compr Physiol, 3, 977–1010.
- Ilyas G, Zhao E, Liu K, et al. (2016). Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1beta. J Hepatol, 64, 118–127. doi:10.1016/j.jhep.2015.08.019
- Jin T, Ding Q, Huang H, et al. (2012). PAQR10 and PAQR11 mediate ras signaling in the golgi apparatus. Cell Res, 22, 661–676. doi:10.1038/cr.2011.161
- Jordan VC. (2006). The science of selective estrogen receptor modulators: concept to clinical practice. Clin Cancer Res, 12, 5010–5013. doi:10.1158/1078-0432.CCR-06-1136
- Jou J, Choi S, Diehl A. (2008). Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis, 28, 370–379. doi:10.1055/s-0028-1091981
- Kamata H, Honda S-I, Maeda S, et al. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, 649–661. doi:10.1016/j.cell.2004.12.041
- Liu F, Ooi VEC, Chang ST. (1997). Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci, 60, 763–771. doi:10.1016/S0024-3205(97)00004-0
- Liu Y, Li F, Zhang L, et al. (2017). Taurine alleviates lipopolysaccharideinduced liver injury by antiinflammation and antioxidants in rats. Mol Med Rep, 16, 6512–6517.
- Liu Y, Zhu L, Liang S, et al. (2015). Galactose protects hepatocytes against TNF-alpha-induced apoptosis by promoting activation of the NF-kappaB signaling pathway in acute liver failure. Lab Invest, 95, 504–514. doi:10.1038/labinvest.2015.34
- Luo M, Liu D, Zhang L, et al. (2012). Protective effects of a novel trimerized sTNFRII on acute liver injury. Int Immunopharmacol, 13, 88–92. doi:10.1016/j.intimp.2012.03.013
- Maes M, Vinken M, Jaeschke H. (2016). Experimental models of hepatotoxicity related to acute liver failure. Toxicol Appl Pharmacol, 290, 86–97. doi:10.1016/j.taap.2015.11.016
- Miyashita T, Toyoda Y, Tsuneyama K, et al. (2012). Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. J Toxicol Sci, 37, 931–942. doi:10.2131/jts.37.931
- Osawa Y, Nagaki M, Banno Y, et al. (2001). Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J Cell Physiol, 187, 374–385. doi:10.1002/(ISSN)1097-4652
- Silverstein R. (2004). D-galactosamine lethality model: scope and limitations. J Endotoxin Res, 10, 147–162.
- Wang K. (2014). Molecular mechanisms of hepatic apoptosis. Cell Death Dis, 5, e996. doi:10.1038/cddis.2013.499
- Yoshikawa Y, Miyashita T, Higuchi S, et al. (2012). Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries. Toxicol Appl Pharmacol, 264, 42–50. doi:10.1016/j.taap.2012.06.023
- Zhang P, Zhang M, Wan M, et al. (2017). Tamoxifen attenuates lipopolysaccharide/galactosamine-induced acute liver failure by antagonizing hepatic inflammation and apoptosis. Immunol Invest, 46, 284–294. doi:10.1080/08820139.2016.1250219